Results 101 to 110 of about 15,828 (290)

PSAgraphics: An R Package to Support Propensity Score Analysis [PDF]

Propensity score analysis is a technique for adjusting for selection bias in observational data. Estimated propensity scores (probability of treatment given observed covariates) are used for stratification of observations. Within strata covariates should
James E. Helmreich, Robert M. Pruzek
core   +1 more source

Abciximab‐Associated Thrombocytopenia After Previous Tirofiban‐Related Thrombocytopenia [PDF]

, 2006
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90080/1/phco.26.3.423 ...
Dorsch, Michael P., Montague, Debbie, Patterson, Cam, Rodgers, Jo Ellen   +3 more
core   +1 more source

Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.

Circulation, 1999
BACKGROUND The TIMI 14 trial tested the hypothesis that abciximab, the Fab fragment of a monoclonal antibody directed to the platelet glycoprotein (GP) IIb/IIIa receptor, is a potent and safe addition to reduced-dose thrombolytic regimens for ST-segment ...
E. Antman, R. Giugliano, C. Gibson, C. Mccabe, P. Coussement, N. Kleiman, A. Vahanian, A. Adgey, I. Menown, H. Rupprecht, R. van der Wieken, J. Ducas, J. Scherer, K. Anderson, F. Van de Werf, E. Braunwald   +15 more
semanticscholar   +1 more source

Investigation of interaction of human platelet membrane components with anticoagulant drugs Abciximab and Eptifibatide

Folia Histochemica et Cytobiologica, 2010
Abciximab (Abci) and eptifibatide (Epti) are antiaggregate drugs which may reduce thrombotic complications inacute coronary syndromes. The aim of this work was the investigation of the interaction between the phospholipid-GPIIb/IIIa glycoprotein complex ...
Ewa Gorodkiewicz, Anna Sankiewicz, Zbigniew A. Figaszewski   +2 more
doaj  

High bolus tirofiban vs abciximab in acute STEMI patients undergoing primary PCI - The tamip study

Heart Views, 2012
Background: Primary percutaneous coronary intervention (PCI) has been shown to be an effective therapy for patients with acute myocardial infarction (MI). Glycoprotein (GP) IIb/IIIa receptor blockers reduce thrombotic complications in patients undergoing
Mohammed A Balghith
doaj   +1 more source

Abciximab [PDF]

Reactions Weekly, 2021
openaire   +1 more source

Gli antagonisti del recettore GPIIb/IIIa: farmacologia, clinica ed economia nelle sindromi coronariche acute NSTEMI e nelle rivascolarizzazioni per via percutanea

Farmeconomia: Health Economics and Therapeutic Pathways, 2005
Inhibition of platelet glycoprotein IIb/IIIa (GP IIb/IIIa) receptor prevents platelet aggregation by controlling its final common pathway, the cross-binding of fibrinogen, bridging across adjacent platelets.
Lorenzo Pradelli
doaj   +1 more source

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

New England Journal of Medicine, 2004
BACKGROUND Whether the glycoprotein IIb/IIIa inhibitor abciximab is beneficial in patients undergoing elective percutaneous coronary intervention after pretreatment with clopidogrel is unknown.
A. Kastrati, J. Mehilli, H. Schühlen, J. Dirschinger, F. Dotzer, J. T. ten Berg, F. Neumann, H. Bollwein, Christian Volmer, M. Gawaz, P. Berger, A. Schömig   +11 more
semanticscholar   +1 more source

Terapia con anticuerpos monoclonales en Cardiología y Medicina Interna

Revista Colombiana de Cardiología, 2016
La terapia biológica basada en anticuerpos monoclonales, constituyen una nueva herramienta terapéutica, que de la mano del desarrollo de la biología molecular permiten intervenir puntos claves en la etiopatogenia de la enfermedad, permitiendo una terapia
Christian David Adams-Sánchez, Gabriel Jaime Tobón-García   +1 more
doaj   +1 more source

Frontiers in interventional cardiology [PDF]

, 1998
n more than 20 years since the first percutaneous coronary revascularization procedures, the field of interventional cardiology has proliferated beyond all expectations. Now more than 1 million procedures are performed worldwide each year.
Serruys, P.W.J.C. (Patrick), Topol, E.J. (Eric)   +1 more
core   +3 more sources